Vertical + Enterprise · Public company · Growth
Recursion
✓ VerifiedRecursion is one of the clearest examples of AI-native biotech at scale, using proprietary biological data and machine learning systems to accelerate drug discovery and platform partnerships.
Editorial intelligence brief
What matters now
Recursion's latest public model milestone is Boltz-2, which now sits alongside its broader Recursion OS 2.0 and Virtual Cell platform work.
Focus: Biotech foundation models and AI-driven drug discovery
Latest funding
Not tracked
No structured event
Tracked funding
Not tracked
No structured events
Latest valuation
Not tracked
No source-backed record
Latest revenue
Not tracked
Growth lifecycle position
Source-backed financial history
Capital and commercial trajectory
Funding, valuation, revenue, and debt are kept separate so unlike measurements are never presented as one trend.
A structured financial history has not been completed for Recursion.
The profile will not manufacture a trend from incomplete or unsourced figures. Each amount must be dated, typed, and linked to public evidence first.
Chronological activity
What changed
Recursion's latest public model milestone is Boltz-2, which now sits alongside its broader Recursion OS 2.0 and Virtual Cell platform work.
A structured event record is still being assembled for this company.
Recent coverage of Recursion
Consolidated by storyProduct surface
Products and model families
Recent models
Products
Open weights
No
API access
No
Review cadence
Weekly
Market position
Lifecycle and strategic signals
Research
Preview
Growth
Deployment
Growth: Public access & scaling
Focus
Biotech foundation models and AI-driven drug discovery
Signals
Taxonomy
Competitive context
Infrastructure & distribution
Where Recursion sits in the AI stack
Model layer
3 tracked model families
Access layer
Application or managed product
Market layer
Vertical + Enterprise
Public product surface
Stack signals
This section reflects publicly visible product and access signals. Undisclosed GPU, cloud, training, and data-center contracts are not inferred.
Evidence trail
Sources and corrections
Primary and public sources used to verify the structured company profile.
The Staticbreaker
Get the signal behind the week's AI changes.
The Staticbreaker turns launches, category shifts, and market noise into a concise editorial briefing.